Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Malignant Mesothelioma to Oncology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Malignant Mesothelioma to Oncology Clinical Trials 22
Clinical Trials by Phase in E7 Countries 24
Clinical Trials in E7 Countries by Trial Status 25
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Malignant Mesothelioma Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Malignant Mesothelioma 38
Nov 07, 2019: MaxCyte to present at BIO-Europe 2019 38
Oct 24, 2019: MaxCyte advances phase I clinical trial of lead CARMA mRNA-based Cell Therapy to third cohort of patients 38
Sep 30, 2019: MaxCyte Presents Updates on First-in-class CARMA Platform at Upcoming Meetings 38
Sep 30, 2019: Mesothelioma trial suggests immunotherapy as an alternative to chemotherapy 39
Clinical Trial Profile Snapshots 41
Appendix 395
Abbreviations 395
Definitions 395
Research Methodology 396
Secondary Research 396
About GlobalData 397
Contact Us 397
Disclaimer 397
Source 398
Malignant Mesothelioma Therapeutics, Global, Clinical Trials by Region, 2019* 8
Malignant Mesothelioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Malignant Mesothelioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Malignant Mesothelioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Malignant Mesothelioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Malignant Mesothelioma Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Malignant Mesothelioma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Malignant Mesothelioma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
Proportion of Malignant Mesothelioma to Oncology Clinical Trials, G7 Countries (%), 2019* 18
Malignant Mesothelioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Malignant Mesothelioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 21
Proportion of Malignant Mesothelioma to Oncology Clinical Trials, E7 Countries (%), 2019* 23
Malignant Mesothelioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
Malignant Mesothelioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
Malignant Mesothelioma Therapeutics, Global, Clinical Trials by Phase, 2019* 26
Malignant Mesothelioma Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 27
Malignant Mesothelioma Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29
Malignant Mesothelioma Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31
Malignant Mesothelioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 32
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37
List of Figures
Malignant Mesothelioma Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Malignant Mesothelioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Malignant Mesothelioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Malignant Mesothelioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
Malignant Mesothelioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
Malignant Mesothelioma Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
Malignant Mesothelioma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
Malignant Mesothelioma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
Proportion of Malignant Mesothelioma to Oncology Clinical Trials, G7 Countries (%), 2019* 17
Malignant Mesothelioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Malignant Mesothelioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of Malignant Mesothelioma to Oncology Clinical Trials, E7 Countries (%), 2019* 22
Malignant Mesothelioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
Malignant Mesothelioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
Malignant Mesothelioma Therapeutics, Global, Clinical Trials by Phase (%), 2019* 26
Malignant Mesothelioma Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 27
Malignant Mesothelioma Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28
Malignant Mesothelioma Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31
Malignant Mesothelioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 32
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 33
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 35
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37
GlobalData Methodology 396
【免責事項】
https://www.marketreport.jp/reports-disclaimer